NEET-PG 2013 - Obstetrics and Gynecology Practice Questions

Q: For routine diagnostic purposes, endometrial biopsy is usually done at which phase of the menstrual cycle?

Just before menstruation. ***Just before menstruation*** - An endometrial biopsy is typically performed in the **late secretory phase (just before menstruation)**. This timing is crucial for evaluating the endometrial response to progesterone and for detecting abnormalities that may be evident during this phase. - This timing allows for the assessment of the **full development of the secretory glands** and stroma, which can reveal issues like **inadequate luteal phase** or **endometrial hyperplasia** more clearly. *10-12 days after menstruation* - This time point corresponds to the mid-proliferative phase, where the endometrium is still growing under **estrogen influence**. - While suitable for evaluating proliferative changes, it might **miss subtle secretory phase abnormalities** or early signs of hyperplasia that are more evident later. *Just after menstruation* - This period is the early proliferative phase, where the endometrium is **thin and regenerating**. - Biopsying at this time might yield insufficient tissue for comprehensive evaluation and would be too early to assess **hormonal responses** that occur later in the cycle. *At the time of ovulation* - Ovulation marks the transition from the proliferative to the secretory phase, influenced by a surge in **luteinizing hormone (LH)**. - An endometrial biopsy at this phase would primarily show a proliferative endometrium and would not provide adequate information about the **key features of the secretory phase**, which are important for diagnostic purposes related to fertility or abnormal bleeding.

Q: What is the most common presenting symptom of TB endometritis?

Infertility. ***Infertility*** - **Infertility** is the most common presenting symptom of **tuberculosis (TB) endometritis**, particularly secondary infertility. - The infection leads to inflammation and scarring of the endometrium and fallopian tubes, impairing implantation and ovum transport. *Abdominal pain* - While **abdominal pain** can occur in TB endometritis, it is typically a less frequent or prominent presenting symptom compared to infertility. - Pain often arises from pelvic inflammation or adhesions but is not the cardinal complaint that prompts diagnosis. *Amenorrhoea* - **Amenorrhea** (absence of menstruation) can be a symptom, especially in advanced cases where there is significant destruction of the endometrium. - It is, however, less common than infertility as the initial presenting symptom. *Vaginal discharge* - **Vaginal discharge** is an uncommon symptom of TB endometritis. - When present, it is often non-specific and not characteristic enough to suggest TB as the underlying cause.

Q: On which day LH & FSH should be measured?

1-3rd day. ***1-3rd day*** - Measuring **LH** (Luteinizing Hormone) and **FSH** (Follicle-Stimulating Hormone) on cycle days 1-3 provides a baseline assessment of **ovarian reserve** and pituitary function. - At this early follicular phase, hormone levels are relatively stable and reflect the intrinsic **gonadal feedback** mechanisms before significant follicular development begins. *7th day* - By day 7, **follicular development** is usually well underway, and FSH levels might be decreasing as a dominant follicle is selected. - Measuring hormones on this day would not provide an accurate baseline assessment, as the levels are already influenced by **follicular growth**. *14th day* - Day 14 is often associated with the **LH surge** that triggers ovulation, making it unsuitable for a baseline assessment of ovarian reserve. - FSH levels would also be significantly different from the early follicular phase due to the ongoing **ovarian cycle events**. *10th day* - On day 10, **estrogen levels** are typically rising, which would already be providing negative feedback to the pituitary, affecting FSH and LH levels. - This timing would not be ideal for assessing baseline hormone levels for **fertility evaluations**.

Q: Which hormone is primarily responsible for insulin resistance during pregnancy?

HPL. ***HPL*** - **Human placental lactogen (HPL)**, also known as **chorionic somatomammotropin**, directly induces maternal insulin resistance to ensure a continuous supply of glucose to the fetus. - HPL levels rise throughout pregnancy, peaking in the third trimester, correlating with increasing insulin resistance. *Estrogen* - While **estrogen** levels are high in pregnancy, its primary role is in supporting uterine growth and maintaining the pregnancy, not directly causing significant insulin resistance. - High estrogen levels can enhance insulin sensitivity in some contexts, contrasting with the overall insulin resistance of pregnancy. *Progesterone* - **Progesterone** is crucial for maintaining pregnancy and relaxing smooth muscle but does not directly cause the marked insulin resistance seen in gestation. - It works synergistically with other hormones but is not the primary driver of glucose intolerance in pregnancy. *GH* - **Growth hormone (GH)** does contribute to insulin resistance in non-pregnant individuals and at high levels can cause insulin resistance, but it is not the primary hormone responsible for the unique physiological insulin resistance of pregnancy. - While GH is present, **HPL** is the dominant somatotropic hormone of pregnancy directly impacting glucose metabolism.

Q: What is the primary maternal cause of fetal macrosomia (large birth weight) in newborns?

Hyperglycemia. ***Hyperglycemia*** - Maternal **hyperglycemia**, often due to **gestational diabetes**, leads to increased glucose transfer across the placenta to the fetus. - This excess glucose stimulates increased fetal insulin production, which acts as a growth hormone causing macrosomia. *Hyperinsulinemia* - While fetal **hyperinsulinemia** directly causes macrosomia by increasing fetal growth, it is a **consequence** of maternal hyperglycemia, not the primary cause itself. - Fetal insulin acts as an anabolic hormone, promoting fat and protein synthesis and overall growth. *Multiparity* - **Multiparity** (having given birth to multiple children) is generally associated with moderately higher birth weights, but it is not the primary cause of macrosomia. - The effect is far less significant and consistent than that of maternal hyperglycemia. *Post maturity* - **Post-term pregnancy** (post maturity) can sometimes be associated with a larger birth weight, but this is less common and less pronounced than macrosomia caused by hyperglycemia. - Fetal growth often slows or even declines in prolonged pregnancies due to placental insufficiency.

Q: What is the recommended management for jaundice due to obstetric cholestasis in the third trimester?

Induction of labour at 38 weeks. ***Induction of labour at 38 weeks*** - **Obstetric cholestasis (Intrahepatic Cholestasis of Pregnancy)** is associated with increased risk of **stillbirth**, particularly beyond 37-38 weeks gestation. - Induction at **37-38 weeks** is recommended to balance reducing stillbirth risk while minimizing prematurity complications. - **Current practice**: Timing depends on **bile acid levels** - delivery at 37-38 weeks for bile acids >40 μmol/L, or 38-39 weeks for milder cases (19-39 μmol/L). - This option represents the standard management approach for most cases of obstetric cholestasis. *Induction of labour at 37 weeks* - Delivery at 37 weeks is also acceptable and increasingly preferred, particularly for **severe disease** (bile acids >40 μmol/L) or when there are additional risk factors. - Both 37 and 38 weeks are within the recommended window; the choice depends on **disease severity** and individual risk assessment. - This is not incorrect, but 38 weeks represents a slightly more conservative approach balancing risks. *Induction of labour at 42 weeks* - Waiting until 42 weeks significantly increases the risk of **intrauterine fetal death (IUFD)** in pregnancies complicated by obstetric cholestasis. - Prolonged exposure to **elevated bile acids** is toxic to the fetus and increases stillbirth risk, especially after 37-38 weeks. - This approach is **contraindicated** in obstetric cholestasis. *Wait for spontaneous labour* - Expectant management beyond 38 weeks is considered **unsafe** due to the unpredictable and progressive risk of **sudden intrauterine death**. - Active management with planned delivery at 37-38 weeks is the standard of care to prevent stillbirth. - Waiting for spontaneous labor exposes the fetus to unacceptable risks.

Q: Red degeneration of fibroid is seen in which of the following?

Mid pregnancy. ***Mid pregnancy*** - **Red degeneration**, or **carneous degeneration**, is most common during the **second and third trimesters of pregnancy** due to increased metabolic demands of the growing fibroid outstripping its blood supply. - The rapid growth leads to **ischemia**, hemorrhage, and necrosis within the fibroid, causing acute abdominal pain. *Early pregnancy* - While fibroids can grow in early pregnancy, **red degeneration** is less common as the uterine blood supply is generally still adequate to meet the fibroid's metabolic needs. - Other forms of degeneration, like **hyaline degeneration**, are more frequently observed in non-pregnant or early pregnant states. *Puerperium* - In the puerperium, fibroids typically undergo **regression** rather than degeneration, as the hormonal stimulation (estrogen and progesterone) that promoted their growth significantly decreases. - The uterus involutes rapidly, and fibroids often shrink. *Nulliparous women* - Nulliparous women can have fibroids and experience various forms of degeneration, but **red degeneration** specifically is rare outside of pregnancy. - Degeneration in nulliparous women is more commonly **hyaline** or **cystic** degeneration.

Q: What is a potential risk for pregnant women who undertake long journeys with prolonged sitting?

Deep vein thrombosis. ***Deep vein thrombosis*** - **Pregnancy** is a **hypercoagulable state** due to increased levels of clotting factors (fibrinogen, factors VII, VIII, X) and decreased protein S activity. - **Prolonged sitting** during long journeys causes **venous stasis** in the lower extremities, which is a key component of **Virchow's triad** for thrombosis (stasis, hypercoagulability, endothelial injury). - **DVT** is the **direct and most specific pathological consequence** of prolonged immobilization during travel in pregnancy. - The risk of **VTE in pregnancy** is **4-5 times higher** than in non-pregnant women, with travel-related DVT being a recognized complication. *Venous thromboembolism* - VTE is an **umbrella term** that encompasses both **DVT and pulmonary embolism**. - While technically correct as a broader category, DVT is the **more specific and direct answer** to what prolonged sitting causes. - In medical education and clinical practice, identifying the **specific pathology** (DVT) is more appropriate than using the general category (VTE). *Pulmonary embolism* - PE is a **complication** of DVT, occurring when a thrombus dislodges and embolizes to the pulmonary circulation. - PE is a **secondary consequence**, not the **primary risk** from prolonged sitting itself. - The direct mechanism of prolonged sitting → venous stasis → **DVT formation** → potential embolization to lungs. *Leg swelling* - **Leg swelling** (edema) is a **symptom**, not a pathological diagnosis. - While leg edema can indicate DVT, it's also common in normal pregnancy due to increased venous pressure and fluid retention. - The question asks for a **risk** (pathological condition), not a symptom.

Question 1

For routine diagnostic purposes, endometrial biopsy is usually done at which phase of the menstrual cycle?

Accepted Answer

Just before menstruation

Answer

10-12 days after menstruation

Answer

Just after menstruation

Answer

At the time of ovulation

Question 2

What is the most common presenting symptom of TB endometritis?

Accepted Answer

Infertility

Answer

Amenorrhoea

Answer

Vaginal discharge

Answer

Abdominal pain

Question 3

On which day LH & FSH should be measured?

Accepted Answer

1-3rd day

Answer

7th day

Answer

14th day

Answer

10th day

Question 4

Which of the following statements about gestational diabetes mellitus (GDM) is true?

Accepted Answer

Gestational diabetes mellitus is first recognized during pregnancy.

Answer

It is always associated with a previous history of IUGR.

Answer

There is no recurrence of GDM in future pregnancies.

Answer

There is no risk of developing overt diabetes in the future.

Question 5

Which hormone is primarily responsible for insulin resistance during pregnancy?

Accepted Answer

HPL

Answer

Estrogen

Answer

Progesterone

Answer

GH

Question 6

What is the primary maternal cause of fetal macrosomia (large birth weight) in newborns?

Accepted Answer

Hyperglycemia

Answer

Hyperinsulinemia

Answer

Multiparity

Answer

Post maturity

Question 7

What is the most common fetal complication associated with gestational diabetes?

Accepted Answer

There is a risk of macrosomia in babies born to mothers with gestational diabetes.

Answer

Only a small percentage of women with gestational diabetes develop overt diabetes.

Answer

Gestational diabetes is usually diagnosed in the second or third trimester.

Answer

Gestational diabetes can increase the risk of congenital malformations.

Question 8

What is the recommended management for jaundice due to obstetric cholestasis in the third trimester?

Accepted Answer

Induction of labour at 38 weeks

Answer

Induction of labour at 37 weeks

Answer

Induction of labour at 42 weeks

Answer

Wait for spontaneous labour

Question 9

Red degeneration of fibroid is seen in which of the following?

Accepted Answer

Mid pregnancy

Answer

Early pregnancy

Answer

Nulliparous women

Answer

Puerperium

Question 10

What is a potential risk for pregnant women who undertake long journeys with prolonged sitting?

Accepted Answer

Deep vein thrombosis

Answer

Venous thromboembolism

Answer

Pulmonary embolism

Answer

Leg swelling

NEET-PG 2013 — Obstetrics and Gynecology